The body begins to look more athletic and proportioned
The new daily obesity pill contains more semaglutide than Rybelsus, which is why it was studied specifically for weight loss
Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide
It has a substantial body of promising preclinical research, but that has not yet translated into robust clinical evidence in humans, says Nora Khaldi, PhD, a Dublin-based molecular scientist and founder of Nuritas, a biotechnology company that uses AI to analyze peptides from plant sources for human health and wellness purposes
Consistent Results: Maintains a reliable 14% average weight loss under real-world conditions, even when accounting for occasionally missed doses
Antioxidant supplementation may support faster results, however, adding supplements at this stage may increase the complexity of the regimen, requiring patients to be diligent and consistent in their approach